IndiaRPG Life Sciences has appointed Deepak Shukla as the new Chief Executive Officer (CEO) of RPG Active Pharma. This appointment marks a leadership change within the pharmaceutical division of the RPG Group, which operates under RPG Life Sciences. Deepak Shukla brings extensive experience in the healthcare and pharmaceutical sectors, having previously held senior roles at various companies. The move is expected to strengthen RPG Active Pharma's strategic direction and operational efficiency. The appointment was officially announced by RPG Life Sciences, reflecting their commitment to advancing their pharmaceutical business.
Bias read (Center): The article reports on a corporate leadership change without any political commentary, framing, or bias. It focuses solely on the business aspect of the appointment and does not take a stance or provide context that would indicate a political lean.
Why factuality (85): The article reports the appointment of Deepak Shukla as CEO of RPG Active Pharma by RPG Life Sciences. It provides the basic factual claim without additional details or sources. Since no primary source was available, factuality is judged based on consistency with cross-source consensus, which suppor
Why objectivity (90): The article presents the information in a neutral tone, simply reporting the appointment without expressing any opinion or bias. The language is straightforward and does not include emotionally charged or subjective language.
